BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10652165)

  • 1. Allergen induced mRNA expression of interleukin-5, but not of interleukin-4 and interferon-gamma, in peripheral blood mononuclear cells obtained before the pollen season predicts the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Kakinoki Y; Ohashi Y; Nakai Y; Washio Y; Nasako Y; Tanaka A; Nakai Y
    Scand J Immunol; 2000 Feb; 51(2):202-8. PubMed ID: 10652165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-induced mRNA expression of IL-5, but not of IL-4 and IFN-gamma, in peripheral blood mononuclear cells is a key feature of clinical manifestation of seasonal allergic rhinitis.
    Nakai Y; Ohashi Y; Kakinoki Y; Tanaka A; Washio Y; Nasako Y; Masamoto T; Sakamoto H; Ohmoto Y
    Arch Otolaryngol Head Neck Surg; 2000 Aug; 126(8):992-6. PubMed ID: 10922233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal changes in phytohemagglutinin-induced cytokine synthesis by peripheral blood lymphocytes of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Tsuda M; Ohashi Y; Washio Y; Kakinoki Y; Nakai Y; Tanaka A; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():156-68. PubMed ID: 9879416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Masamoto T; Kato A; Washio Y; Yamada K; Hayashi M; Ohmoto Y
    Scand J Immunol; 1998 Jun; 47(6):596-602. PubMed ID: 9652829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lol p I-induced IL-4 and IFN-gamma production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season.
    Gagnon R; Akoum A; Hébert J
    J Allergy Clin Immunol; 1993 Apr; 91(4):950-6. PubMed ID: 8473684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of seasonal increase in serum interleukin-5 is linked to the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Hayashi M; Ohashi Y; Tanaka A; Kakinoki Y; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():133-42. PubMed ID: 9879413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy affects the seasonal increase in specific IgE and interleukin-4 in serum of patients with seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Kakinoki Y; Ohno Y; Tanaka A; Masamoto T; Sakamoto H; Washio Y; Kato A
    Scand J Immunol; 1997 Jul; 46(1):67-77. PubMed ID: 9246210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy.
    Söderlund A; Gabrielsson S; Paulie S; Hammarström ML; Rak S; Troye-Blomberg M
    Immunol Lett; 1997 Jun; 57(1-3):177-81. PubMed ID: 9232448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.
    Imada M; Simons FE; Jay FT; Hayglass KT
    Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pollen immunotherapy inhibits T helper 1 and 2 cell responses, but suppression of T helper 2 cell response is a more important mechanism related to the clinical efficacy.
    Kakinoki Y; Ohashi Y; Nakai Y; Tanaka A; Washio Y
    Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):63-70. PubMed ID: 10628713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
    Movérare R; Elfman L; Björnsson E; Stålenheim G
    Immunol Lett; 2000 Jul; 73(1):51-6. PubMed ID: 10963811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of seasonal exposure to pollen on nonspecific interleukin-4, interleukin-5, and interferon-gamma in vitro release by peripheral blood mononuclear cells from subjects with pollinosis.
    Muñoz-Bellido FJ; Monteseirín FJ; Escribano MM; Delgado J; Velázquez E; Conde J
    Allergy; 1998 Apr; 53(4):420-5. PubMed ID: 9580416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.
    Wachholz PA; Nouri-Aria KT; Wilson DR; Walker SM; Verhoef A; Till SJ; Durham SR
    Immunology; 2002 Jan; 105(1):56-62. PubMed ID: 11849315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.
    El Bassam S; Pinsonneault S; Kornfeld H; Ren F; Menezes J; Laberge S
    Immunology; 2006 Jan; 117(1):89-96. PubMed ID: 16423044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in expression of IL-4 and IL-5 mRNA in the nasal mucosa of patients with perennial allergic rhinitis during natural allergen exposure.
    Lee CH; Rhee CS; Oh SH; Min YG; Lee MS
    Ann Otol Rhinol Laryngol; 1997 Mar; 106(3):215-9. PubMed ID: 9078933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.
    Hinz D; Seumois G; Gholami AM; Greenbaum JA; Lane J; White B; Broide DH; Schulten V; Sidney J; Bakhru P; Oseroff C; Wambre E; James EA; Kwok WW; Peters B; Vijayanand P; Sette A
    Clin Exp Allergy; 2016 May; 46(5):705-19. PubMed ID: 26662458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.